Long-Term Efficacy and Safety of Zolpidem Extended-Release 12.5 mg, Administered 3 to 7 Nights Per Week for 24 Weeks, in Patients With Chronic Primary Insomnia: A 6-Month, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter Study

STUDY OBJECTIVES: To evaluate long-term efficacy and safety of zolpidem extended-release 3 to 7 nights/week for chronic primary insomnia. DESIGN: Multicenter, 25-week, phase IIIb, randomized, double-blind, placebo-controlled, parallel-group. SETTING: Outpatient; visits every 4 weeks. PATIENTS: Aged...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Krystal, Andrew D., Erman, Milton, Zammit, Gary K., Soubrane, C., Roth, Thomas
Formato: Artigo
Idioma:Inglês
Publicado em: Associated Professional Sleep Societies, LLC 2008
Assuntos:
Chronic Primary Insomnia
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC2225552/
https://ncbi.nlm.nih.gov/pubmed/18220081
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados